Biosidus
Biosidus, officially known as Biosidus S.A., is a prominent biopharmaceutical company headquartered in Argentina. Established in 1996, the company has made significant strides in the biotechnology sector, focusing on the development and production of biopharmaceuticals, particularly in the fields of oncology, haematology, and immunology. With a strong presence in Latin America and expanding operations globally, Biosidus is renowned for its innovative biosimilars and high-quality biopharmaceutical products. The company’s commitment to research and development has positioned it as a leader in the industry, achieving notable milestones such as the successful launch of several biosimilar therapies. Biosidus stands out for its dedication to improving patient outcomes through advanced biotechnological solutions, making it a key player in the biopharmaceutical landscape.
DitchCarbon Score
How does Biosidus's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biosidus's score of 5 is lower than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Biosidus's reported carbon emissions
In 2023, Biosidus reported total carbon emissions of approximately 2,652,000 kg CO2e, comprising about 756,000 kg CO2e from Scope 1 and about 1,896,000 kg CO2e from Scope 2 emissions. This represents a decrease from 2022, where total emissions were about 2,719,000 kg CO2e, with Scope 1 at approximately 873,000 kg CO2e and Scope 2 at about 1,846,000 kg CO2e. Despite these reductions, there are currently no specific reduction targets or climate pledges disclosed by Biosidus. The company has not outlined any initiatives under the Science Based Targets initiative (SBTi) or other formal reduction commitments. Biosidus continues to focus on sustainability, as indicated by their emissions intensity metrics, which reflect their commitment to improving energy efficiency and reducing their carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 766,000 | 000,000 | 000,000 |
| Scope 2 | 1,521,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biosidus is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
